Leuprorelin EP Impurity K is a related variant arising from synthetic or degradation steps. Subtle residue differences modify conformational landscapes and retention behavior. Researchers analyze it to strengthen impurity identification and process understanding. Applications include stability testing, analytical-method validation, and peptide-route refinement.
CAT No: Z10-101-174
Synonyms/Alias:(S)-1-((2-((S)-2-((S)-3-(1H-imidazol-4-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanamido)-3-(1H-indol-3-yl)propanamido)acryloyl)-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl)-N-ethylpyrrolidine-2-carboxamide
Leuprorelin (Leuprolide) EP Impurity K is a synthetic peptide impurity structurally related to the well-characterized gonadotropin-releasing hormone (GnRH) analog, leuprorelin. As an identified European Pharmacopoeia (EP) impurity, this compound holds particular significance in the context of pharmaceutical quality control, peptide characterization, and analytical method development. Its presence and quantification are crucial for ensuring the integrity and safety of leuprorelin-based formulations, making it a valuable reference standard and research tool in peptide analysis and pharmaceutical development.
Analytical method development: Leuprorelin (Leuprolide) EP Impurity K is frequently utilized as a reference standard in the development and validation of chromatographic and spectrometric methods for peptide drug substances. Its inclusion allows researchers and quality control laboratories to optimize separation parameters, assess method specificity, and establish robust detection protocols for impurity profiling. Accurate characterization of this impurity facilitates the reliable quantification of related substances in complex peptide formulations, supporting regulatory compliance and product consistency.
Pharmaceutical quality control: In the manufacturing and release testing of leuprorelin-based drug products, monitoring for known impurities such as EP Impurity K is essential. The compound serves as a benchmark for system suitability and performance verification in high-performance liquid chromatography (HPLC) and related analytical assays. Its presence enables the precise determination of impurity levels, ensuring that pharmaceutical products meet stringent quality standards and minimizing the risk of uncharacterized contaminants in the final formulation.
Peptide synthesis process evaluation: The occurrence of EP Impurity K during solid-phase peptide synthesis or subsequent purification steps provides insight into the efficiency and selectivity of synthetic protocols. By quantifying and tracking this impurity, process chemists can identify potential degradation pathways, optimize reaction conditions, and enhance the overall yield and purity of the target peptide. Such process monitoring contributes to the refinement of synthetic methodologies and supports the production of high-quality peptide APIs.
Structural elucidation and degradation studies: As a structurally defined impurity, Leuprorelin (Leuprolide) EP Impurity K is instrumental in elucidating degradation mechanisms and assessing the stability of peptide drug substances. Its use in forced degradation studies and stability-indicating assays aids in the identification of potential breakdown products, informing both formulation development and shelf-life determination. Understanding the formation and behavior of this impurity under various stress conditions is critical for comprehensive risk assessment and product safety evaluation.
Reference material for regulatory submissions: The availability of well-characterized peptide impurities such as EP Impurity K is integral to the preparation of regulatory dossiers and technical documentation. It is commonly employed as a reference material for impurity identification, quantitation, and reporting in accordance with pharmacopoeial requirements. Its inclusion in analytical studies enhances the credibility and completeness of impurity profiles submitted to regulatory agencies, facilitating the approval process for peptide-based pharmaceutical products.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More